Overview
Discounted cash flow
Income / accounting-based
Multiples & assets
Scenario
Toolbox
Weighted blend
$18.75
+15.31% vs spot
Buy
Spot price
$16.26
Mkt cap $18.94B
subtle cardAnalyst PT consensus
$15.25
-6.21% vs spot
subtle cardMethods covered
10 / 11
7 in blend
subtle cardFootball field
VTRS · fair-value range by method
Method comparison
VTRS · fair value by valuation framework
| Method | Category | Fair value | Range | vs spot | Weight | Driver | Conf. |
|---|---|---|---|---|---|---|---|
| DCF · FCFF | dcf | $23.54 | $26.53 – $43.80 | +44.79% | 35.7% | WACC 5.7%, g₀=-5.0%, gₗ=2.0% | high |
| DCF · FCFE | dcf | $16.43 | $19.14 – $22.10 | +1.07% | 26.8% | kₑ 8.3%, g₀=-5.0%, gₗ=2.0% | high |
| DDM · Gordon | ddm | $8.37 | $7.23 – $9.94 | -48.52% | — | D₁ 0.52, kₑ 8.3%, gₗ 2.0% | low |
| DDM · H-model | ddm | $5.50 | $7.23 – $7.99 | -66.18% | — | D₀ 0.52, g₀=-5.0%, gₗ=2.0%, H 5y | low |
| DDM · multi-stage | ddm | $7.09 | $6.03 – $8.16 | -56.39% | 8.9% | 5y schedule -5.0% → 2.0%, kₑ 8.3% | low |
| Residual income | income | $5.87 | $5.17 – $6.58 | -63.89% | 17.9% | BV 13.66, ROE -23.9% → kₑ | low |
| P/S · sector | multiple | $53.11 | $45.14 – $61.07 | +226.61% | 5.4% | Rev/sh 13.28 × peer P/S 4.00 | med |
| EV / Sales | multiple | $32.74 | $27.83 – $37.65 | +101.37% | 3.6% | Sales × peer 3.40× − ND | med |
| Book NAV | asset | $13.66 | $12.98 – $14.34 | -16.00% | 1.8% | (Assets − Liabilities) / Shares | high |
| Liquidation | asset | $3.67 | $3.12 – $4.23 | -77.40% | — | Cash 100% + non-cash 70% − Liab. | low |
| Reverse DCF | reverse | — | — | — | — | Implied g -8.9% · Pessimistic — market pricing decline | high |
Cost-of-capital build-up
CAPM cost of equity, after-tax cost of debt, WACC. Risk-free as of 2026-05-12.
| Risk-free rate (US 10y Treasury)rf | 4.46% |
| Equity beta (0.87)β | × 0.87 |
| Equity risk premiumERP | 4.46% |
| Cost of equity (CAPM)kₑ | 8.35% |
| Pre-tax cost of debtkd | 3.21% |
| Effective tax ratet | 4.1% |
| After-tax cost of debt | 3.07% |
| Equity weight$14.7B | 50.0% |
| Debt weight$14.7B | 50.0% |
| WACC | 5.71% |
Growth assumptions
Blended forward growth used as DCF default; terminal pegged to long-run nominal GDP.
| Analyst forward revenue growthFMP | 3.17% |
| Analyst forward EPS growthFMP | — |
| Historical 5y revenue CAGRFY | -5.44% |
| Historical 5y EPS CAGRFY | -97.35% |
| Sustainable g (ROE × retention)Δ | -23.89% |
| Blended near-term growth (g₀) | -5.00% |
| Terminal growth (gₗ) | 2.00% |
Sources
- FMP /analyst-estimates— 8 rows(as of 2022-12-30)
- Treasury rates · 10y— 4.46% rf(as of 2026-05-12)
- market_risk_premium · DB— 4.46% ERP(as of 2026-05-13)
- Sector multiple defaults— Healthcare (live sector PE unavailable)
- FMP /price-target-consensus— mean $15.25
This page is generated by a quantitative valuation engine for research purposes only and does not constitute investment advice. Methodology follows standard CFA / Damodaran frameworks; assumptions are driven by analyst consensus from Financial Modeling Prep and reported financial statements.